May 2017

Letter from the Editor

May 1, 2017

The act of giving In this month’s cover story, we shine a light on the philanthropic and social responsibility initiatives being undertaken by just a few life-sciences companies. In fact, pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable giving, philanthropy, and corporate […]

Upfront

May 1, 2017

Sandoz Names Winners of Healthcare Access Challenge Sandoz, a Novartis division, named the three winners of its inaugural Healthcare Access Challenge (Sandoz HACk). The winners, chosen by a panel of judges at the Wired Health 2017 event in London, identified innovative approaches to address health access challenges in Ghana, the Maldives, and the Philippines. The […]

Innovator’s Corner

May 1, 2017

Harnessing the Body’s Own Pathways to Silence Genes Douglas Fambrough, Ph.D., President and CEO of Dicerna Pharmaceuticals, talks about his company’s research to develop RNAi therapeutics, a newer approach to drug discovery and development. About 20,000 genes in the human body are deployed in various ways in different tissues. When inappropriately expressed, these genes can […]

HealthTech

May 1, 2017

Pregnant Women, an Understudied Population, Get Insights App Trend Watch: ResearchKit, VR, and other tech innovations are improving patient monitoring. WebMD and Scripps Translational Science Institute have launched a study to understand factors that contribute to healthy pregnancies, using WebMD’s upgraded iPhone pregnancy app paired with Apple’s ResearchKit to advance research on positive pregnancy outcomes. […]

Last Word

May 1, 2017

Better Monitoring of Opioids Purdue Pharma’s VP and Chief Medical Officer, Gail Cawkwell, M.D., Ph.D., talks about the need to integrate state prescription monitoring programs — state-run electronic databases to track prescribing and dispensing of controlled prescription drugs — with electronic health records. PV: How do state prescription monitoring programs work? Cawkwell: With the caveat […]

Philanthropy: Beyond the Numbers

May 1, 2017

Pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable giving, philanthropy, and corporate responsibility. Over the years, pharma has repeatedly been named as a top industry corporate donor, rivaled only by the finance industry. The Reputation Institute, The Chronicle of Philanthropy, The Conference […]

Behind the Brand — Lessons Learned

May 1, 2017

According to the global branding and design firm Landor, the process of managing brands — or brand governance — has changed dramatically in recent  years. The command-and-control model is obsolete in today’s more agile and dynamic marketplace. In this new world, multiple communities, including employees, partners, third-party influencers, and superfans, are actively encouraged to become […]

HBA Rising Stars & Luminaries: A Vision of the Future

May 1, 2017

PharmaVOICE asked the nearly 100 industry executives identified by their companies as HBA Rising Stars and Luminaries to identify the biggest trends they believe will impact the industry in the next few years. Top on their lists are innovation and value. They also tackle the topics of big data, patient-centricity, and health and wellness. For […]

Hepatitis Market Update

May 1, 2017

In just a few short years, hepatitis infections could go from a serious disease to one that will be rare. Pharmaceutical companies have done much to address hepatitis in recent years. Today, hepatitis B is preventable with vaccination, and recent advances in treatment have made hepatitis C curable. The National Academies Of Sciences, Engineering, and […]

Rare Recruitment

May 1, 2017

Efforts to bring treatments to market for the approximately 7,000 rare diseases affecting more than 350 million people globally have been stepped up in recent years. But in order to bring products to market, companies must conduct clinical trials with a large enough patient population — relative to the incidence of the disease — to […]

SHOWCASE FEATURE: mHealth: Seeing the Potential in mHealth

May 1, 2017

Mobile is ubiquitous. Consumers use mobile apps to search for information about everything from retail products to news and sports and, increasingly, to monitor their health. A report from comScore found that mobile now represents 65% of digital media time, and that desktop computers are becoming the secondary touchpoint for many U.S. consumers. This is […]

The Impact of mHealth on Real-World Data Collection

May 1, 2017

Advancements in technology over the past five years have led to increased interest around the topic of mHealth — the monitoring and delivery of healthcare through mobile devices. Approximately 93% of us now own a mobile phone and, with an increased desire from the pharmaceutical industry to use electronic data capture over traditional paper methods, […]

A Patient-Centric Approach to mHealth

May 1, 2017

The possibilities for mHealth solutions are vast and expanding, so how can pharmaceutical brands know how to enter the space, or even if they should? Consider Your Patients First Patients are actively searching for ways to live healthier lives, prevent illness, manage chronic conditions, and keep their healthcare costs down. Today’s patients, particularly those in […]

mHealth Evolution

May 1, 2017

Ten years after the launch of Apple’s iPhone in 2007, mobile healthcare (mHealth) technology and consumer adoption continues to advance. mHealth is a general term for the use of mobile wireless technology for medical care, health, and fitness. As the global population moves from being digitally naïve to digitally savvy, mHealth will likely become mainstream […]

Speak Out

May 1, 2017

Welcome to the Jungle: The Dilemma of the Healthcare Challenger Brand Marketing a pharmaceutical product or medical device to a healthcare professional audience has changed radically, even for market leaders and establishment brands. But for challenger brands—the brands with something to prove, obstacles to overcome, perceptions to change—the dilemma is even bigger. They need to […]

FEEDBACK